Successful treatment of multidrug-resistant Acinetobacter baumanii ventriculitis with intravenous and intraventricular colistin

References

• Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21:538–82.
   Google Scholar
• Kralinsky K, Krcmeryova T, Tuharsky J, Krcmery V. Nosocomial Acinetobacter meningitis. Pediatr Infect Dis J 2000; 19:270–1.
   PubMed Web of Science ®Google Scholar
• Ho YH, Wang LS, Chao HJ, Chang KC, Su CF. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin. J Microbiol Immunol Infect 2007; 40:537–40.
   PubMedGoogle Scholar
• Kasiakou SK, Michalopoulos A, Soteriades ES, Samonis G, Sermaides GJ, Falagas ME. Combination therapy with intravenous colistin for management of infections due to multidrug- resistant Gram-negative bacteria in patientswithout cystic fibrosis. Antimicrob Agents Chemother 2005; 49:3136–46.
   PubMed Web of Science ®Google Scholar
• Markou N, Apostolakos H, Koumoudiou C, et al. Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care 2003; 7: R78–83.
   PubMed Web of Science ®Google Scholar
• Jimenez-Mejias ME, Pichardo-Guerrero C, Marquez-Rivas FJ, Martin-Lozano D, Prados T, Pachon J. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. EurJ Clin Microbiol Infect Dis 2002; 21:212–14.
   PubMed Web of Science ®Google Scholar
• Jimenez-Mejias ME, Becerril B, Marquez-Rivas FJ, Pichardo C, Cuberos L, Pachon J. Successful treatment of multidrug-resistant Acinetobacter bau- mannii meningitis with intravenous colistin sulfo- methate sodium. Eur J Clin Microbiol Infect Dis 2000; 19:970–1.
   PubMed Web of Science ®Google Scholar
• Fernandez-Viladrich P, Corbella X, Corral L, Tubau F, Mateu A. Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium. Clin Infect Dis 1999; 28:916–17.
   PubMed Web of Science ®Google Scholar
• Ng J, Gosbell IB, Kelly JA, Boyle MJ, Ferguson JK. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventri- cular or intrathecal colistin: case series and literature review. J Antimicrob Chemother 2006; 58:1078–81.
   PubMed Web of Science ®Google Scholar
• Price DJ, Sleigh JD. Klebsiella meningitis—report of nine cases. J Neurol Neurosurg Psychiatry 1972; 35:903–8.
   PubMed Web of Science ®Google Scholar
• Swift PN, Bushby SR. Haemophilus influenza meningitis treated with polymyxin. Lancet 1951; 2:183–90.
   Google Scholar
• Kaplan SL, Patrick CC. Cefotaxime and aminoglycoside treatment of meningitis caused by gramnegative enteric organisms. Pediatr Infect Dis J 1990; 9:810–14.
   PubMed Web of Science ®Google Scholar
• Cetin ES, Durmaz R, Tetik T, Otlu B, Kaya S, Caliçkan A. Epidemiologic characterization of nosocomial Acinetobacter baumannii infections in a Turkish university hospital by pulsed-field gel electrophoresis. AmJ Infect Control 2009; 37:56–64.
   PubMed Web of Science ®Google Scholar
• Agodi A, Zarrilli R, Barchitta M, et al. Alert surveillance of intensive care unit-acquired Acinetobacter infections in a Sicilian hospital. Clin Microbiol Infect 2006; 12:241–7.
   PubMed Web of Science ®Google Scholar
• Go ES, Urban C, Burns J, et al. Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 1994; 344:1329–32.
   PubMed Web of Science ®Google Scholar
• Kuo LC, Teng LJ, Yu CJ, Ho SW, Hsueh PR. Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a university hospital in Taiwan. J Clin Microbiol 2004; 42:1759–63.
   PubMed Web of Science ®Google Scholar
• Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez FJ, et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 2003; 36:1111–18.
   PubMed Web of Science ®Google Scholar
• Linden PK, Kusne S, Coley K, Fontes P, Kramer DJ, Paterson D. Use of parenteral colistin for the treatment of serious infection due to antimicrobial- resistant Pseudomonas aeruginosaiClin Infect Dis 2003; 37: e154–60.
   PubMed Web of Science ®Google Scholar
• Reina R, Estenssoro E, Saenz G, et al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med 2005; 31:1058–65.
   PubMed Web of Science ®Google Scholar
• Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 2005; 11:115–21.
   PubMed Web of Science ®Google Scholar
• Pintado V, San Miguel LG, Grill F, et al. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria. J Infect 2008; 56:185–90.
   PubMed Web of Science ®Google Scholar
• Vasen W, Desmery P, Ilutovich S, Di Martino A. Intrathecal use of colistin. J Clin Microbiol 2000; 38:3523.
   PubMed Web of Science ®Google Scholar
• Sueke H, Marsh H, Dhital A. Using intrathecal colistin for multidrug resistant shunt infection. Br J Neurosurg 2005; 19:51–2.
   PubMed Web of Science ®Google Scholar
• Bukhary Z, Mahmood W, Al-Khani A, Al-Abdely HM. Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin. Saudi Med J 2005; 26:656–8.
   PubMed Web of Science ®Google Scholar
• Berlana D, Llop JM, Fort E, Badia MB, Jodar R. Use of colistin in the treatment of multiple-drug- resistant gram-negative infections. Am J Health Syst Pharm 2005; 62:39–47.
   PubMed Web of Science ®Google Scholar
• Benifla M, Zucker G, Cohen A, Alkan M. Successful treatment of Acinetobacter meningitis with intrathecal polymyxin E. J Antimicrob Chemother 2004; 54:290–2.
   PubMed Web of Science ®Google Scholar
• Levin AS, Barone AA, Penco J, et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumanniiiClin Infect Dis 1999; 28:1008–11.
   Google Scholar
• Rodriguez Guardado A, Blanco A, Asensi V, et al. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother 2008; 61:908–13.
   PubMed Web of Science ®Google Scholar
• Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267–84.
   PubMed Web of Science ®Google Scholar